NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

間質幹細胞 (MSC)的市場趨勢、市場佔有率、市場規模的預測 (2021-2028年):各產品&服務類型、來源 (骨髓、臍帶血)、適應症、用途、地區

Mesenchymal Stem Cells Market Size, Share & Trends Analysis Report By Product & Services, By Type, By Source Of Isolation (Bone Marrow, Cord Blood), By Indication, By Application, By Region, And Segment Forecasts, 2021 - 2028

出版商 Grand View Research, Inc. 商品編碼 1007484
出版日期 內容資訊 英文 140 Pages
商品交期: 2-10個工作天內
價格
間質幹細胞 (MSC)的市場趨勢、市場佔有率、市場規模的預測 (2021-2028年):各產品&服務類型、來源 (骨髓、臍帶血)、適應症、用途、地區 Mesenchymal Stem Cells Market Size, Share & Trends Analysis Report By Product & Services, By Type, By Source Of Isolation (Bone Marrow, Cord Blood), By Indication, By Application, By Region, And Segment Forecasts, 2021 - 2028
出版日期: 2021年05月12日內容資訊: 英文 140 Pages
簡介

全球間質幹細胞 (MSC)的市場規模在預測期間內預計以12.6%的年複合成長率發展,成長到2028年61億美元的規模。

臨床應用的擴大,開發平台的強化,市場競爭加劇等要素預計促進該市場的成長。還有新型冠狀病毒感染疾病 (COVID-19)的世界性流行預計促進臨床應用和投資。

本報告提供全球間質幹細胞 (MSC)的市場調查,市場定義和概要,新型冠狀病毒感染疾病 (COVID-19)以及其他的市場影響因素分析,技術趨勢,市場規模的變化、預測,產品&服務、類型、來源、適應症、用途、地區/主要國家等各種區分的明細,競爭環境,主要企業簡介等資訊彙整。

第1章 調查手法、調查範圍

第2章 摘要整理

第3章 市場可變因素、趨勢、展望

  • 市場預測
  • 技術概要
  • 市場動態
  • 普及、成長預測製圖
  • SWOT分析
  • 波特分析
  • COVID-19:影響分析
  • 主要交易、策略性聯盟
  • 公開企業
  • 非公開企業

第4章 市場預測、趨勢分析:各產品、服務

  • 各工作流程
    • 電池單元採購、分類
    • 培養、凍結保存
    • 分化
    • 特性評估
  • 各產品
    • 細胞、細胞株
    • 套件、媒體、試劑
    • 其他
  • 服務

第5章 市場預測、趨勢分析:各類型

  • 自體
  • 同種異體

第6章 市場預測、趨勢分析:各來源

  • 骨髓
  • 臍帶血
  • 末梢血
  • 輸卵管
  • 胎兒肝臟
  • 脂肪組織

第7章 市場預測、趨勢分析:各適應症

  • 骨、軟骨的修復
  • 循環系統疾病
  • 發炎性疾病、免疫疾病
  • 肝疾病
  • 癌症
  • GvHD
  • 其他

第8章 市場預測、趨勢分析:各用途

  • 疾病建模
  • 醫藥品開發、發現
  • 幹細胞銀行
  • 人組織工程
  • 毒物學研究
  • 其他

第9章 市場預測、趨勢分析:各地區、主要國家

  • 北美
  • 歐洲
  • 亞太地區
  • 南美
  • 中東、非洲

第10章 企業簡介

  • 策略性架構
  • 進入經營者的分類
  • 企業簡介
目錄
Product Code: GVR-4-68039-361-1

Mesenchymal Stem Cells Market Growth & Trends

The global mesenchymal stem cells market size is expected to reach USD 6.1 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 12.6% from 2021 to 2028. Mesenchymal stem cells (MSCs) are set to gain popularity among healthcare professionals, to develop novel therapeutics, primarily targeted at the treatment of several immune-mediated disorders. MSCs have been acclaimed effective as a regenerative therapy for skeletal tissue repair and have recently gained traction across modulation of immune cells and endogenous tissues.

Expanding clinical applications of mesenchymal stem cells, strengthening the pipeline of these therapies, along with intensifying market competition are some of the key aspects driving the industry expansion of MSCs. The recent pandemic outbreak of COVID-19 is set to propel the clinical applications and investments done in this market space. For instance, in April 2020, Canada's The Stem Cell Network (SCN) provided funding of USD 300,000 to the project targeted towards the evaluation of optimal dosage of MSCs, to design an effective therapeutic approach to reduce the impacts of respiratory disorders associated with SARS-CoV-2 infection.

Additionally, as stated by clinicaltrials.gov, 21 clinical trials reportedly incorporated MSCs in the management of COVID-19. Apart from the applications of MSCs in regenerative medicine and tissue engineering, the MSCs serve as a potent therapeutic approach for cancer treatment. As of February 2020, 25 clinical trials have been registered that employ MSCs in the treatment of several cancer indications. This is set to drive the mesenchymal stem cells market (MSCs) market.

Acknowledging the profitable opportunities posed by the market, key industry participants are focused towards initiating technological collaborations to strengthen their market presence. In August 2020, NantKwest Inc. collaborated with Generate Life Sciences Co. to develop a mesenchymal stem cell-based treatment against COVID-19. The latter company is providing with the MSCs derived from donated umbilical cord tissues.

Mesenchymal Stem Cells Market Report Highlights

Widespread use of bone marrow derived MSCs in several therapeutic applications has resulted in the segment's dominance in 2020

More than 20.0% of clinical trials incorporate bone marrow MSCs, which is set to maintain the segment's largest revenue share up to 2028

The cancer indication segment is expected to witness rapid growth through 2021 to 2028, attributed to the emergence of MSCs as a promising vehicle for anti-cancer drugs

This is attributed to the tumor tropism ability of MSCs and their ability to manage the predestination of tumor cells

Disease modelling application generated the highest revenue in 2020, owing to several advantages associated with MSCs such as the high capacity of expansion and self-renewal and reduced tumorigenic capacity, which makes them suitable across disease modelling applications

The kits, media, and reagents segment held a significant revenue share in 2020 owing to the presence of a substantial number of service providers and increasing demand in the market

The allogeneic segment dominated the market in 2020; Implantation of allogeneic mesenchymal stem cells serves as a promising tool for cell-based therapy

As of August 2019, more than 200 clinical trials have been reported for use of allogeneic MSCs, which is expected to propel the segment's revenue generation capacity from 2021 to 2028

Apart from the availability of advanced research facilities and skilled professionals, favorable government initiatives and high R&D expenditure, active policies pertaining to cell therapies have contributed to the dominance of North America MSCs market in 2020

For instance, in August 2020, the Centers for Medicare and Medicaid Services proposed new policies that include cellular therapies, wherein, commercial insurance companies support private health plans associated with MSCs

The key players are engaged in exploring MSC therapy to its highest potential across different emerging applications, contributing to market growth

For instance, in July 2020, Promedica presented positive results from its study that evaluated the use of allogeneic MSCs in COVID-19 patients. The study was conducted under the U.S. FDA's Emergency Investigational New Drug (IND) approval

Table of Contents

Chapter 1 Methodology And Scope

  • 1.1 Research Methodology
  • 1.2 Research Assumptions
    • 1.2.1 Estimates And Forecast Timeline
  • 1.3 Research Methodology
  • 1.4 Information Procurement
    • 1.4.1 Purchased Database
    • 1.4.2 GVR'S Internal Database
    • 1.4.3 Secondary Sources
    • 1.4.4 Primary Research
    • 1.4.5 Details Of Primary Research
  • 1.5 Information or Data Analysis
    • 1.5.1 Data Analysis Models
  • 1.6 Market Formulation & Validation
  • 1.7 Model Details
    • 1.7.1 Commodity Flow Analysis
      • 1.7.1.1 Approach 1: Commodity Flow Approach
      • 1.7.1.2 Approach 2: Country-Wise Market Estimation Using Bottom-Up Approach
  • 1.8 Market: CAGR Calculation
  • 1.9 List of Secondary Sources
  • 1.10 List of Primary Sources
  • 1.11 Objectives
    • 1.11.1 Objective 1:
    • 1.11.2 Objective 2:

Chapter 2 Executive Summary

  • 2.1 Competition Milieu
  • 2.2 Segment Outlook

Chapter 3 Market Variables, Trends, & Scope

  • 3.1 Market Lineage Outlook
    • 3.1.1 Parent Market Outlook
    • 3.1.2 Ancillary Market Outlook
  • 3.2 Technology Overview
  • 3.3 Market Dynamics
    • 3.3.1 Market Driver Analysis
      • 3.3.1.1 Expanding Pipeline And Clinical Studies Of Mesenchymal Stem Cell Based Products
      • 3.3.1.2 Emerging Applications of MSCs
      • 3.3.1.3 Rising Market Competition Among Key Players
    • 3.3.2 Market Restraint Analysis
      • 3.3.2.1 Lack Of Standardized & Regulated Delivery of Stem Cell Therapy
      • 3.3.2.2 Ethical & Safety Concerns Controversies Associated With Human MSC Therapy
    • 3.3.3 Market Opportunity Analysis
      • 3.3.3.1 Use Of Mesenchymal Stem Cells In Regenerative Medicine
  • 3.4 Penetration & Growth Prospect Mapping for Applications, 2020
  • 3.5 Mesenchymal Stem Cells Market-SWOT Analysis, by Factor (Political & Legal, Economic, and Technological)
  • 3.6 Industry Analysis - Porter's
  • 3.7 COVID-19 Impact Analysis
  • 3.8 Major Deals & Strategic Alliances Analysis
    • 3.8.1 Mergers & Acquisitions
    • 3.8.2 Technological Collaborations
    • 3.8.3 Licensing & Partnership
    • 3.8.4 Strategic Divestments
  • 3.9 Public Companies
    • 3.9.1 Competitive Dashboard Analysis
    • 3.9.2 Market Differentiators
  • 3.10 Private Companies
    • 3.10.1 List Of Emerging Players
    • 3.10.2 Funding Outlook

Chapter 4 Mesenchymal Stem Cells (MSCs) Market: Product & Services Business Analysis

  • 4.1 Mesenchymal Stem Cells Market: Product & Services Movement Analysis
  • 4.2 By Workflow
    • 4.2.1 Cell Sourcing And Isolation
      • 4.2.1.1 Mesenchymal Stem Cell Sourcing And Isolation Market Estimates And Forecast, 2017 - 2028 (USD Million)
    • 4.2.2 Culture & Cryopreservation
      • 4.2.2.1 Mesenchymal Stem Cell Culture & Cryopreservation Market Estimates And Forecast, 2017 - 2028 (USD Million)
    • 4.2.3 Differentiation
      • 4.2.3.1 Mesenchymal Stem Cell Differentiation Market Estimates And Forecast, 2017 - 2028 (USD Million)
    • 4.2.4 Characterization
      • 4.2.4.1 Mesenchymal Stem Cell Characterization Market Estimates And Forecast, 2017 - 2028 (USD Million)
  • 4.3 By Product
    • 4.3.1 Cells & Cell Lines
      • 4.3.1.1 Mesenchymal Stem Cells And Cell Lines Market Estimates And Forecast, 2017 - 2028 (USD Million)
    • 4.3.2 Kits, Media & Reagents
      • 4.3.2.1 Mesenchymal Stem Cell Kits, Media & Reagents Market Estimates And Forecast, 2017 - 2028 (USD Million)
    • 4.3.3 Others
      • 4.3.3.1 Others Mesenchymal Stem Cell Products Market Estimates And Forecast, 2017 - 2028 (USD Million)
  • 4.4 Services
    • 4.4.1 Mesenchymal Stem Cell Services Market Estimates And Forecast, 2017 - 2028 (USD Million)

Chapter 5 Mesenchymal Stem Cells (MSCs) Market: Type Business Analysis

  • 5.1 Mesenchymal Stem Cells Market: Type Movement Analysis
  • 5.2 Autologous
    • 5.2.1 Autologous MSCs Market Estimates And Forecast, 2017 - 2028 (USD Million)
  • 5.3 Allogeneic
    • 5.3.1 Allogeneic MSCs Market Estimates And Forecast, 2017 - 2028 (USD Million)

Chapter 6 Mesenchymal Stem Cells (MSCs) Market: Source Of Isolation Business Analysis

  • 6.1 Mesenchymal Stem Cells Market: Source Of Isolation Movement Analysis
  • 6.2 Bone Marrow
    • 6.2.1 Bone Marrow Derived MSCs Estimates And Forecast, 2017 - 2028 (USD Million)
  • 6.3 Cord Blood
    • 6.3.1 Cord Blood Derived MSCs Estimates And Forecast, 2017 - 2028 (USD Million)
  • 6.4 Peripheral Blood
    • 6.4.1 Peripheral Blood Derived MSCs Estimates And Forecast, 2017 - 2028 (USD Million)
  • 6.5 Fallopian Tube
    • 6.5.1 Fallopian Tube Derived MSCs Estimates And Forecast, 2017 - 2028 (USD Million)
  • 6.6 Fetal Liver
    • 6.6.1 Fetal Liver Derived MSCs Estimates And Forecast, 2017 - 2028 (USD Million)
  • 6.7 Lung
    • 6.7.1 Lung Derived MSCs Estimates And Forecast, 2017 - 2028 (USD Million)
  • 6.8 Adipose Tissues
    • 6.8.1 Adipose Tissue Derived MSCs Estimates And Forecast, 2017 - 2028 (USD Million)

Chapter 7 Mesenchymal Stem Cells (MSCs) Market: Indication Business Analysis

  • 7.1 Mesenchymal Stem Cells Market: Indication Movement Analysis
  • 7.2 Bone & Cartilage Repair
    • 7.2.1 Mesenchymal Stem Cells (MSCs) Market Estimates And Forecast For Bone & Cartilage Repair, 2017 - 2028 (USD Million)
  • 7.3 Cardiovascular Disease
    • 7.3.1 Mesenchymal Stem Cells (MSCs) Market Estimates And Forecast For Cardiovascular Diseases, 2017 - 2028 (USD Million)
  • 7.4 Inflammatory And Immunological Disease
    • 7.4.1 Mesenchymal Stem Cells (MSCs) Market Estimates And Forecast For Inflammatory And Immunological Diseases, 2017 - 2028 (USD Million)
  • 7.5 Liver Diseases
    • 7.5.1 Mesenchymal Stem Cells (MSCs) Market Estimates And Forecast For Liver Diseases, 2017 - 2028 (USD Million)
  • 7.6 Cancer
    • 7.6.1 Mesenchymal Stem Cells (MSCs) Market Estimates And Forecast For Cancer, 2017 - 2028 (USD Million)
  • 7.7 GvHD
    • 7.7.1 Mesenchymal Stem Cells (MSCs) Market Estimates And Forecast For GvHD, 2017 - 2028 (USD Million)
  • 7.8 Others
    • 7.8.1 Mesenchymal Stem Cells (MSCs) Market Estimates And Forecast For Others, 2017 - 2028 (USD Million)

Chapter 8 Mesenchymal Stem Cells (MSCs) Market: Application Business Analysis

  • 8.1 Mesenchymal Stem Cells Market: Application Movement Analysis
  • 8.2 Disease Modeling
    • 8.2.1 Mesenchymal Stem Cells (MSCs) Market Estimates And Forecast For Disease Modeling, 2017 - 2028 (USD Million)
  • 8.3 Drug Development & Discovery
    • 8.3.1 Mesenchymal Stem Cells (MSCs) Market Estimates And Forecast For Drug Development & Discovery, 2017 - 2028 (USD Million)
  • 8.4 Stem Cell Banking
    • 8.4.1 Mesenchymal Stem Cells (MSCs) Market Estimates And Forecast For Stem Cell Banking, 2017 - 2028 (USD Million)
  • 8.5 Tissue Engineering
    • 8.5.1 Mesenchymal Stem Cells (MSCs) Market Estimates And Forecast For Tissue Engineering, 2017 - 2028 (USD Million)
  • 8.6 Toxicology Studies
    • 8.6.1 Mesenchymal Stem Cells (MSCs) Market Estimates And Forecast For Toxicology Studies, 2017 - 2028 (USD Million)
  • 8.7 Others
    • 8.7.1 Mesenchymal Stem Cells (MSCs) Market Estimates And Forecast For Others, 2017 - 2028 (USD Million)

Chapter 9 Mesenchymal Stem Cells (MSCs) Market: Regional Business Analysis

  • 9.1 Mesenchymal Stem Cells (Mscs) Market: Regional Movement Analysis
  • 9.2 North America
    • 9.2.1 North America Mesenchymal Stem Cells (Mscs) Market Estimates And Forecast, By Product & Services, 2017 - 2028 (USD Million)
    • 9.2.2 North America Mesenchymal Stem Cells (Mscs) Market Estimates And Forecast, By Type, 2017 - 2028 (USD Million)
    • 9.2.3 North America Mesenchymal Stem Cells (Mscs) Market Estimates And Forecast, By Source Of Isolation, 2017 - 2028 (USD Million)
    • 9.2.4 North America Mesenchymal Stem Cells (Mscs) Market Estimates And Forecast, By Indication, 2017 - 2028 (USD Million)
    • 9.2.5 North America Mesenchymal Stem Cells (Mscs) Market Estimates And Forecast, By Application, 2017 - 2028 (USD Million)
    • 9.2.6 U.S.
      • 9.2.6.1 U.S. Mesenchymal Stem Cells (Mscs) Market Estimates And Forecast, 2017 - 2028 (USD Million)
    • 9.2.7 Canada
      • 9.2.7.1 Canada Mesenchymal Stem Cells (Mscs) Market Estimates And Forecast, 2017 - 2028 (USD Million)
  • 9.3 Europe
    • 9.3.1 Europe Mesenchymal Stem Cells (Mscs) Market Estimates And Forecast, By Product & Services, 2017 - 2028 (USD Million)
    • 9.3.2 Europe Mesenchymal Stem Cells (Mscs) Market Estimates And Forecast, By Type, 2017 - 2028 (USD Million)
    • 9.3.3 Europe Mesenchymal Stem Cells (Mscs) Market Estimates And Forecast, By Source Of Isolation, 2017 - 2028 (USD Million)
    • 9.3.4 Europe Mesenchymal Stem Cells (Mscs) Market Estimates And Forecast, By Indication, 2017 - 2028 (USD Million)
    • 9.3.5 Europe Mesenchymal Stem Cells (Mscs) Market Estimates And Forecast, By Application, 2017 - 2028 (USD Million)
    • 9.3.6 U.K.
      • 9.3.6.1 U.K. Mesenchymal Stem Cells (Mscs) Market Estimates And Forecast, 2017 - 2028 (USD Million)
    • 9.3.7 Germany
      • 9.3.7.1 Germany Mesenchymal Stem Cells (Mscs) Market Estimates And Forecast, 2017 - 2028 (USD Million)
    • 9.3.8 France
      • 9.3.8.1 France Mesenchymal Stem Cells (Mscs) Market Estimates And Forecast, 2017 - 2028 (USD Million)
    • 9.3.9 Italy
      • 9.3.9.1 Italy Mesenchymal Stem Cells (Mscs) Market Estimates And Forecast, 2017 - 2028 (USD Million)
  • 9.4 Asia Pacific
    • 9.4.1 Asia Pacific Mesenchymal Stem Cells (Mscs) Market Estimates And Forecast, By Product & Services, 2017 - 2028 (USD Million)
    • 9.4.2 Asia Pacific Mesenchymal Stem Cells (Mscs) Market Estimates And Forecast, By Type, 2017 - 2028 (USD Million)
    • 9.4.3 Asia Pacific Mesenchymal Stem Cells (Mscs) Market Estimates And Forecast, By Source Of Isolation, 2017 - 2028 (USD Million)
    • 9.4.4 Asia Pacific Mesenchymal Stem Cells (Mscs) Market Estimates And Forecast, By Indication, 2017 - 2028 (USD Million)
    • 9.4.5 Asia Pacific Mesenchymal Stem Cells (Mscs) Market Estimates And Forecast, By Application, 2017 - 2028 (USD Million)
    • 9.4.6 China
      • 9.4.6.1 China Mesenchymal Stem Cells (Mscs) Market Estimates And Forecast, 2017 - 2028 (USD Million)
    • 9.4.7 Japan
      • 9.4.7.1 Japan Mesenchymal Stem Cells (Mscs) Market Estimates And Forecast, 2017 - 2028 (USD Million)
    • 9.4.8 India
      • 9.4.8.1 India Mesenchymal Stem Cells (Mscs) Market Estimates And Forecast, 2017 - 2028 (USD Million)
    • 9.4.9 South Korea
      • 9.4.9.1 South Korea Mesenchymal Stem Cells (Mscs) Market Estimates And Forecast, 2017 - 2028 (USD Million)
  • 9.5 Latin America
    • 9.5.1 Latin America Mesenchymal Stem Cells (Mscs) Market Estimates And Forecast, By Product & Services, 2017 - 2028 (USD Million)
    • 9.5.2 Latin America Mesenchymal Stem Cells (Mscs) Market Estimates And Forecast, By Type, 2017 - 2028 (USD Million)
    • 9.5.3 Latin America Mesenchymal Stem Cells (Mscs) Market Estimates And Forecast, By Source Of Isolation, 2017 - 2028 (USD Million)
    • 9.5.4 Latin America Mesenchymal Stem Cells (Mscs) Market Estimates And Forecast, By Indication, 2017 - 2028 (USD Million)
    • 9.5.5 Latin America Mesenchymal Stem Cells (Mscs) Market Estimates And Forecast, By Application, 2017 - 2028 (USD Million)
    • 9.5.6 Brazil
      • 9.5.6.1 Brazil Mesenchymal Stem Cells (Mscs) Market Estimates And Forecast, 2017 - 2028 (USD Million)
    • 9.5.7 Mexico
      • 9.5.7.1 Mexico Mesenchymal Stem Cells (Mscs) Market Estimates And Forecast, 2017 - 2028 (USD Million)
  • 9.6 Middle East & Africa (Mea)
    • 9.6.1 Mea Mesenchymal Stem Cells (Mscs) Market Estimates And Forecast, By Product & Services, 2017 - 2028 (USD Million)
    • 9.6.2 Mea Mesenchymal Stem Cells (Mscs) Market Estimates And Forecast, By Type, 2017 - 2028 (USD Million)
    • 9.6.3 Mea Mesenchymal Stem Cells (Mscs) Market Estimates And Forecast, By Source Of Isolation, 2017 - 2028 (USD Million)
    • 9.6.4 Mea Mesenchymal Stem Cells (Mscs) Market Estimates And Forecast, By Indication, 2017 - 2028 (USD Million)
    • 9.6.5 Mea Mesenchymal Stem Cells (Mscs) Market Estimates And Forecast, By Application, 2017 - 2028 (USD Million)
    • 9.6.6 South Africa
      • 9.6.6.1 South Africa Mesenchymal Stem Cells (Mscs) Market Estimates And Forecast, 2017 - 2028 (USD Million)
    • 9.6.7 Saudi Arabia
      • 9.6.7.1 Saudi Arabia Mesenchymal Stem Cells (Mscs) Market Estimates And Forecast, 2017 - 2028 (USD Million)

Chapter 10 Company Profile

  • 10.1 Strategy Framework
  • 10.2 Market Participation Categorization
  • 10.3 Company Profiles
    • 10.3.1 THERMO FISHER SCIENTIFIC
      • 10.3.1.1 Company Overview
      • 10.3.1.2 Financial Performance
      • 10.3.1.3 Product Benchmarking
      • 10.3.1.4 Strategic Initiatives
    • 10.3.2 CELL APPLICATIONS, INC.
      • 10.3.2.1 Company Overview
      • 10.3.2.2 Financial Performance
      • 10.3.2.3 Product Benchmarking
      • 10.3.2.4 Strategic Initiatives
    • 10.3.3 CYAGEN BIOSCIENCES INC.
      • 10.3.3.1 Company Overview
      • 10.3.3.2 Financial Performance
      • 10.3.3.3 Product Benchmarking
    • 10.3.4 AXOL BIOSCIENCES LTD.
      • 10.3.4.1 Company Overview
      • 10.3.4.2 Financial Performance
      • 10.3.4.3 Product Benchmarking
      • 10.3.4.4 Strategic Initiatives
    • 10.3.5 CYTORI THERAPEUTICS INC
      • 10.3.5.1 Company Overview
      • 10.3.5.2 Financial Performance
      • 10.3.5.3 Product Benchmarking
      • 10.3.5.4 Strategic Initiatives
    • 10.3.6 STEMCELL TECHNOLOGIES INC.
      • 10.3.6.1 Company Overview
      • 10.3.6.2 Financial Performance
      • 10.3.6.3 Product Benchmarking
      • 10.3.6.4 Strategic Initiatives
    • 10.3.7 CELPROGEN INC.
      • 10.3.7.1 Company Overview
      • 10.3.7.2 Financial Performance
      • 10.3.7.3 Product Benchmarking
      • 10.3.7.4 Strategic Initiatives
    • 10.3.8 BRAINSTORM CELL THERAPEUTICS INC.
      • 10.3.8.1 Company Overview
      • 10.3.8.2 Financial Performance
      • 10.3.8.3 Product Benchmarking
      • 10.3.8.4 Strategic Initiatives
    • 10.3.9 STEMEDICA CELL TECHNOLOGIES INC.
      • 10.3.9.1 Company Overview
      • 10.3.9.2 Financial Performance
      • 10.3.9.3 Product Benchmarking
      • 10.3.9.4 Strategic Initiatives
    • 10.3.10 MERCK KGAA (MILLIPORESIGMA)
      • 10.3.10.1 Company Overview
      • 10.3.10.2 Financial Performance
      • 10.3.10.3 Product Benchmarking
      • 10.3.10.4 Strategic Initiatives
    • 10.3.11 SMITH+NEPHEW
      • 10.3.11.1 Company Overview
      • 10.3.11.2 Osiris Therapeutics Inc.
      • 10.3.11.3 Financial Performance
      • 10.3.11.4 Product Benchmarking
      • 10.3.11.5 Strategic Initiatives
    • 10.3.12 LONZA AG
      • 10.3.12.1 Company Overview
      • 10.3.12.2 Financial Performance
      • 10.3.12.3 Product Benchmarking
    • 10.3.13 PROMOCELL GMBH
      • 10.3.13.1 Company Overview
      • 10.3.13.2 Financial Performance
      • 10.3.13.3 Product Benchmarking
      • 10.3.13.4 Strategic Initiatives
    • 10.3.14 SCIENCELL RESEARCH LABORATORIES
      • 10.3.14.1 Company Overview
      • 10.3.14.2 Financial Performance
      • 10.3.14.3 Product Benchmarking
    • 10.3.15 AMERICAN TYPE CULTURE COLLECTION
      • 10.3.15.1 Company Overview
      • 10.3.15.2 Financial Performance
      • 10.3.15.3 Product Benchmarking

List of Tables

  • Table 1 List of secondary sources
  • Table 2 Comparison between the large-scale bioprocessing strategies for mesenchymal stem cells
  • Table 3 Approved MSC based products (as of 2020)
  • Table 4 Approved MSC based products (as of 2020)
  • Table 5 Examples of commercially available bone marrow derived MSCs and related products
  • Table 6 Completed and ongoing trials of MSCs in heart disease
  • Table 7 Recently started or planned clinical trials (As of September 2019)
  • Table 8 Clinical studies using MSC-based therapies for cancer treatment
  • Table 9 North America mesenchymal stem cells (MSCs) market estimates and forecast by product & services, 2017 - 2028 (USD Million)
  • Table 10 North America mesenchymal stem cells (MSCs) market estimates and forecast by type, 2017 - 2028 (USD Million)
  • Table 11 North America mesenchymal stem cells (MSCs) market estimates and forecast by source of isolation, 2017 - 2028 (USD Million)
  • Table 12 North America mesenchymal stem cells (MSCs) market estimates and forecast by indication, 2017 - 2028 (USD Million)
  • Table 13 North America mesenchymal stem cells (MSCs) market estimates and forecast by application, 2017 - 2028 (USD Million)
  • Table 14 U.S. mesenchymal stem cells (MSCs) market estimates and forecast by product & services, 2017 - 2028 (USD Million)
  • Table 15 U.S. mesenchymal stem cells (MSCs) market estimates and forecast by type, 2017 - 2028 (USD Million)
  • Table 16 U.S. mesenchymal stem cells (MSCs) market estimates and forecast by source of isolation, 2017 - 2028 (USD Million)
  • Table 17 U.S. mesenchymal stem cells (MSCs) market estimates and forecast by indication, 2017 - 2028 (USD Million)
  • Table 18 U.S. mesenchymal stem cells (MSCs) market estimates and forecast by application, 2017 - 2028 (USD Million)
  • Table 19 Canada mesenchymal stem cells (MSCs) market estimates and forecast by product & services, 2017 - 2028 (USD Million)
  • Table 20 Canada mesenchymal stem cells (MSCs) market estimates and forecast by type, 2017 - 2028 (USD Million)
  • Table 21 Canada mesenchymal stem cells (MSCs) market estimates and forecast by source of isolation, 2017 - 2028 (USD Million)
  • Table 22 Canada mesenchymal stem cells (MSCs) market estimates and forecast by indication, 2017 - 2028 (USD Million)
  • Table 23 Canada mesenchymal stem cells (MSCs) market estimates and forecast by application, 2017 - 2028 (USD Million)
  • Table 24 Europe mesenchymal stem cells (MSCs) market estimates and forecast by product & services, 2017 - 2028 (USD Million)
  • Table 25 Europe mesenchymal stem cells (MSCs) market estimates and forecast by type, 2017 - 2028 (USD Million)
  • Table 26 Europe mesenchymal stem cells (MSCs) market estimates and forecast by source of isolation, 2017 - 2028 (USD Million)
  • Table 27 Europe mesenchymal stem cells (MSCs) market estimates and forecast by indication, 2017 - 2028 (USD Million)
  • Table 28 Europe mesenchymal stem cells (MSCs) market estimates and forecast by application, 2017 - 2028 (USD Million)
  • Table 29 U.K. mesenchymal stem cells (MSCs) market estimates and forecast by product & services, 2017 - 2028 (USD Million)
  • Table 30 U.K. mesenchymal stem cells (MSCs) market estimates and forecast by type, 2017 - 2028 (USD Million)
  • Table 31 U.K. mesenchymal stem cells (MSCs) market estimates and forecast by source of isolation, 2017 - 2028 (USD Million)
  • Table 32 U.K. mesenchymal stem cells (MSCs) market estimates and forecast by indication, 2017 - 2028 (USD Million)
  • Table 33 U.K. mesenchymal stem cells (MSCs) market estimates and forecast by application, 2017 - 2028 (USD Million)
  • Table 34 Germany mesenchymal stem cells (MSCs) market estimates and forecast by product & services, 2017 - 2028 (USD Million)
  • Table 35 Germany mesenchymal stem cells (MSCs) market estimates and forecast by type, 2017 - 2028 (USD Million)
  • Table 36 Germany mesenchymal stem cells (MSCs) market estimates and forecast by source of isolation, 2017 - 2028 (USD Million)
  • Table 37 Germany mesenchymal stem cells (MSCs) market estimates and forecast by indication, 2017 - 2028 (USD Million)
  • Table 38 Germany mesenchymal stem cells (MSCs) market estimates and forecast by application, 2017 - 2028 (USD Million)
  • Table 39 France mesenchymal stem cells (MSCs) market estimates and forecast by product & services, 2017 - 2028 (USD Million)
  • Table 40 France mesenchymal stem cells (MSCs) market estimates and forecast by type, 2017 - 2028 (USD Million)
  • Table 41 France mesenchymal stem cells (MSCs) market estimates and forecast by source of isolation, 2017 - 2028 (USD Million)
  • Table 42 France mesenchymal stem cells (MSCs) market estimates and forecast by indication, 2017 - 2028 (USD Million)
  • Table 43 France mesenchymal stem cells (MSCs) market estimates and forecast by application, 2017 - 2028 (USD Million)
  • Table 44 Italy mesenchymal stem cells (MSCs) market estimates and forecast by product & services, 2017 - 2028 (USD Million)
  • Table 45 Italy mesenchymal stem cells (MSCs) market estimates and forecast by type, 2017 - 2028 (USD Million)
  • Table 46 Italy mesenchymal stem cells (MSCs) market estimates and forecast by source of isolation, 2017 - 2028 (USD Million)
  • Table 47 Italy mesenchymal stem cells (MSCs) market estimates and forecast by indication, 2017 - 2028 (USD Million)
  • Table 48 Italy mesenchymal stem cells (MSCs) market estimates and forecast by application, 2017 - 2028 (USD Million)
  • Table 49 Asia Pacific mesenchymal stem cells (MSCs) market estimates and forecast by product & services, 2017 - 2028 (USD Million)
  • Table 50 Asia Pacific mesenchymal stem cells (MSCs) market estimates and forecast by type, 2017 - 2028 (USD Million)
  • Table 51 Asia Pacific mesenchymal stem cells (MSCs) market estimates and forecast by source of isolation, 2017 - 2028 (USD Million)
  • Table 52 Asia Pacific mesenchymal stem cells (MSCs) market estimates and forecast by indication, 2017 - 2028 (USD Million)
  • Table 53 Asia Pacific mesenchymal stem cells (MSCs) market estimates and forecast by application, 2017 - 2028 (USD Million)
  • Table 54 China mesenchymal stem cells (MSCs) market estimates and forecast by product & services, 2017 - 2028 (USD Million)
  • Table 55 China mesenchymal stem cells (MSCs) market estimates and forecast by type, 2017 - 2028 (USD Million)
  • Table 56 China mesenchymal stem cells (MSCs) market estimates and forecast by source of isolation, 2017 - 2028 (USD Million)
  • Table 57 China mesenchymal stem cells (MSCs) market estimates and forecast by indication, 2017 - 2028 (USD Million)
  • Table 58 China mesenchymal stem cells (MSCs) market estimates and forecast by application, 2017 - 2028 (USD Million)
  • Table 59 Japan mesenchymal stem cells (MSCs) market estimates and forecast by product & services, 2017 - 2028 (USD Million)
  • Table 60 Japan mesenchymal stem cells (MSCs) market estimates and forecast by type, 2017 - 2028 (USD Million)
  • Table 61 Japan mesenchymal stem cells (MSCs) market estimates and forecast by source of isolation, 2017 - 2028 (USD Million)
  • Table 62 Japan mesenchymal stem cells (MSCs) market estimates and forecast by indication, 2017 - 2028 (USD Million)
  • Table 63 Japan mesenchymal stem cells (MSCs) market estimates and forecast by application, 2017 - 2028 (USD Million)
  • Table 64 India mesenchymal stem cells (MSCs) market estimates and forecast by product & services, 2017 - 2028 (USD Million)
  • Table 65 India mesenchymal stem cells (MSCs) market estimates and forecast by type, 2017 - 2028 (USD Million)
  • Table 66 India mesenchymal stem cells (MSCs) market estimates and forecast by source of isolation, 2017 - 2028 (USD Million)
  • Table 67 India mesenchymal stem cells (MSCs) market estimates and forecast by indication, 2017 - 2028 (USD Million)
  • Table 68 India mesenchymal stem cells (MSCs) market estimates and forecast by application, 2017 - 2028 (USD Million)
  • Table 69 South Korea mesenchymal stem cells (MSCs) market estimates and forecast by product & services, 2017 - 2028 (USD Million)
  • Table 70 South Korea mesenchymal stem cells (MSCs) market estimates and forecast by type, 2017 - 2028 (USD Million)
  • Table 71 South Korea mesenchymal stem cells (MSCs) market estimates and forecast by source of isolation, 2017 - 2028 (USD Million)
  • Table 72 South Korea mesenchymal stem cells (MSCs) market estimates and forecast by indication, 2017 - 2028 (USD Million)
  • Table 73 South Korea mesenchymal stem cells (MSCs) market estimates and forecast by application, 2017 - 2028 (USD Million)
  • Table 74 Latin America mesenchymal stem cells (MSCs) market estimates and forecast by product & services, 2017 - 2028 (USD Million)
  • Table 75 Latin America mesenchymal stem cells (MSCs) market estimates and forecast by type, 2017 - 2028 (USD Million)
  • Table 76 Latin America mesenchymal stem cells (MSCs) market estimates and forecast by source of isolation, 2017 - 2028 (USD Million)
  • Table 77 Latin America mesenchymal stem cells (MSCs) market estimates and forecast by indication, 2017 - 2028 (USD Million)
  • Table 78 Latin America mesenchymal stem cells (MSCs) market estimates and forecast by application, 2017 - 2028 (USD Million)
  • Table 79 Brazil mesenchymal stem cells (MSCs) market estimates and forecast by product & services, 2017 - 2028 (USD Million)
  • Table 80 Brazil mesenchymal stem cells (MSCs) market estimates and forecast by type, 2017 - 2028 (USD Million)
  • Table 81 Brazil mesenchymal stem cells (MSCs) market estimates and forecast by source of isolation, 2017 - 2028 (USD Million)
  • Table 82 Brazil mesenchymal stem cells (MSCs) market estimates and forecast by indication, 2017 - 2028 (USD Million)
  • Table 83 Brazil mesenchymal stem cells (MSCs) market estimates and forecast by application, 2017 - 2028 (USD Million)
  • Table 84 Mexico mesenchymal stem cells (MSCs) market estimates and forecast by product & services, 2017 - 2028 (USD Million)
  • Table 85 Mexico mesenchymal stem cells (MSCs) market estimates and forecast by type, 2017 - 2028 (USD Million)
  • Table 86 Mexico mesenchymal stem cells (MSCs) market estimates and forecast by source of isolation, 2017 - 2028 (USD Million)
  • Table 87 Mexico mesenchymal stem cells (MSCs) market estimates and forecast by indication, 2017 - 2028 (USD Million)
  • Table 88 Mexico mesenchymal stem cells (MSCs) market estimates and forecast by application, 2017 - 2028 (USD Million)
  • Table 89 Middle East & Africa mesenchymal stem cells (MSCs) market estimates and forecast by product & services, 2017 - 2028 (USD Million)
  • Table 90 Middle East & Africa mesenchymal stem cells (MSCs) market estimates and forecast by type, 2017 - 2028 (USD Million)
  • Table 91 Middle East & Africa mesenchymal stem cells (MSCs) market estimates and forecast by source of isolation, 2017 - 2028 (USD Million)
  • Table 92 Middle East & Africa mesenchymal stem cells (MSCs) market estimates and forecast by indication, 2017 - 2028 (USD Million)
  • Table 93 Middle East & Africa mesenchymal stem cells (MSCs) market estimates and forecast by application, 2017 - 2028 (USD Million)
  • Table 94 South Africa mesenchymal stem cells (MSCs) market estimates and forecast by product & services, 2017 - 2028 (USD Million)
  • Table 95 South Africa mesenchymal stem cells (MSCs) market estimates and forecast by type, 2017 - 2028 (USD Million)
  • Table 96 South Africa mesenchymal stem cells (MSCs) market estimates and forecast by source of isolation, 2017 - 2028 (USD Million)
  • Table 97 South Africa mesenchymal stem cells (MSCs) market estimates and forecast by indication, 2017 - 2028 (USD Million)
  • Table 98 South Africa mesenchymal stem cells (MSCs) market estimates and forecast by application, 2017 - 2028 (USD Million)
  • Table 99 Saudi Arabia mesenchymal stem cells (MSCs) market estimates and forecast by product & services, 2017 - 2028 (USD Million)
  • Table 100 Saudi Arabia mesenchymal stem cells (MSCs) market estimates and forecast by type, 2017 - 2028 (USD Million)
  • Table 101 Saudi Arabia mesenchymal stem cells (MSCs) market estimates and forecast by source of isolation, 2017 - 2028 (USD Million)
  • Table 102 Saudi Arabia mesenchymal stem cells (MSCs) market estimates and forecast by indication, 2017 - 2028 (USD Million)
  • Table 103 Saudi Arabia mesenchymal stem cells (MSCs) market estimates and forecast by application, 2017 - 2028 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Stem cell market pyramid
  • Fig. 9 Market trends & outlook
  • Fig. 10 Mesenchymal Stem Cells (MSCs) market driver impact
  • Fig. 11 Market restraint impact
  • Fig. 12 Penetration & growth prospect mapping for products, 2020
  • Fig. 13 SWOT analysis, by factor (Political & legal, economic, and technological)
  • Fig. 14 Porter's Five Forces Analysis
  • Fig. 15 Mesenchymal Stem Cells (MSCs) market: Product & services outlook and key takeaways
  • Fig. 16 Mesenchymal Stem Cells (MSCs) market: Product & services movement analysis
  • Fig. 17 Mesenchymal stem cell sourcing and isolation market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 18 Mesenchymal stem cell culture & cryopreservation market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 19 Mesenchymal stem cell differentiation market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 20 Mesenchymal stem cell characterization market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 21 Mesenchymal stem cells and cell lines market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 22 Mesenchymal stem cell kits, media & reagents market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 23 Other mesenchymal stem cell products market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 24 Mesenchymal stem cell services market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 25 Mesenchymal stem cells (MSCs) market: Type outlook and key takeaways
  • Fig. 26 Mesenchymal stem cells (MSCs) market: Type movement analysis
  • Fig. 27 Autologous MSCs market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 28 Allogeneic MSCs market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 29 Mesenchymal stem cells (MSCs) market: Source of isolation outlook and key takeaways
  • Fig. 30 Mesenchymal stem cells (MSCs) market: Source of isolation movement analysis
  • Fig. 31 Bone marrow derived MSCs market estimates and forecast, 2017 - 2028 (USD billion)
  • Fig. 32 Bone marrow derived MSCs market estimates and forecast, 2017 - 2028 (USD billion)
  • Fig. 33 Adipose tissue derived MSCs market estimates and forecast, 2017 - 2028 (USD billion)
  • Fig. 34 Other sources derived MSCs market estimates and forecast, 2017 - 2028 (USD billion)
  • Fig. 35 Mesenchymal stem cells (MSCs) market: Indication outlook and key takeaways
  • Fig. 36 Mesenchymal stem cells (MSCs) market: Indication movement analysis
  • Fig. 37 MSCs market estimates and forecast for bone & cartilage repair, 2017 - 2028 (USD Million)
  • Fig. 38 MSCs market estimates and forecast for cardiovascular diseases, 2017 - 2028 (USD Million)
  • Fig. 39 MSCs market estimates and forecast for inflammatory and immunological diseases, 2017 - 2028 (USD Million)
  • Fig. 40 MSCs market estimates and forecast for liver diseases, 2017 - 2028 (USD Million)
  • Fig. 41 MSCs market estimates and forecast for cancers, 2017 - 2028 (USD Million)
  • Fig. 42 MSCs market estimates and forecast for GvHD, 2017 - 2028 (USD Million)
  • Fig. 43 MSCs market estimates and forecast for others, 2017 - 2028 (USD Million)
  • Fig. 44 Mesenchymal Stem Cells (MSCs) market: Application outlook and key takeaways
  • Fig. 45 Mesenchymal Stem Cells (MSCs) market: Application movement analysis
  • Fig. 46 MSCs market estimates and forecast for disease modeling, 2017 - 2028 (USD Million)
  • Fig. 47 MSCs market estimates and forecast for drug development & discovery, 2017 - 2028 (USD Million)
  • Fig. 48 MSCs market estimates and forecast for stem cell banking, 2017 - 2028 (USD Million)
  • Fig. 49 MSCs market estimates and forecast for tissue engineering, 2017 - 2028 (USD Million)
  • Fig. 50 MSCs market estimates and forecast for toxicology studies, 2017 - 2028 (USD Million)
  • Fig. 51 MSCs market estimates and forecast for Others, 2017 - 2028 (USD Million)
  • Fig. 52 Mesenchymal stem cells (MSCs) market: Regional outlook and key takeaways
  • Fig. 53 Mesenchymal stem cells (MSCs) market: Regional movement analysis
  • Fig. 54 North America mesenchymal stem cells (MSCs) market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 55 U.S. mesenchymal stem cells (MSCs) market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 56 Canada mesenchymal stem cells (MSCs) market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 57 Europe mesenchymal stem cells (MSCs) market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 58 U.K. mesenchymal stem cells (MSCs) market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 59 Germany mesenchymal stem cells (MSCs) market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 60 France mesenchymal stem cells (MSCs) market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 61 Italy mesenchymal stem cells (MSCs) market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 62 Asia Pacific mesenchymal stem cells (MSCs) market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 63 China mesenchymal stem cells (MSCs) market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 64 Japan mesenchymal stem cells (MSCs) market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 65 India mesenchymal stem cells (MSCs) market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 66 South Korea mesenchymal stem cells (MSCs) market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 67 Latin America mesenchymal stem cells (MSCs) market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 68 Brazil mesenchymal stem cells (MSCs) market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 69 Mexico mesenchymal stem cells (MSCs) market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 70 Middle East & Africa mesenchymal stem cells (MSCs) market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 71 South Africa mesenchymal stem cells (MSCs) market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 72 Saudi Arabia mesenchymal stem cells (MSCs) market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 73 Strategy framework
  • Fig. 74 Market participation categorization